ENGENSIS

Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 09 Jun 2025)

What this means for you

Registered since 12 Mar 2019. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
87777607
Registration number
5694789
Mark type
Stylized text
Filed
31 Jan 2018
Published for opposition
02 Oct 2018
Registered
12 Mar 2019
Attorney of record
Daniel P. Mullarkey

Goods and services

  • Class 005 — Pharmaceuticals: Chemical reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; diagnostic preparations for medical purposes for detecting mutation in prion genes; preparations for medical purposes for detecting mutation in prion genes; chemical preparations for pharmaceutical purposes, namely, for painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; drugs for medical purposes, namely, prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; medicines for human purposes, namely, pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for diagnosis of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; ethical medicinal preparations, namely, pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical preparations for use in medical DNA analysis; genetic treatment pharmaceutical preparations
  • Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research and development of vaccines and medicines; scientific research in the fields of biomedicine; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services

Owner

Prosecution history

  • 09 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 09 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 09 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 13 Feb 2025 — TEAS SECTION 8 & 15 RECEIVED
  • 12 Mar 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 19 Jun 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 10 May 2019 — REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
  • 12 Mar 2019 — REGISTERED-PRINCIPAL REGISTER
  • 05 Feb 2019 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
  • 21 Dec 2018 — NOTICE OF ALLOWANCE CANCELLED
  • 05 Feb 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 21 Dec 2018 — TEAS DELETE 1(B) BASIS RECEIVED
  • 27 Nov 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 02 Oct 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 02 Oct 2018 — PUBLISHED FOR OPPOSITION

View this trademark record on Marksy